Stock data
Lexaria Bioscience Corp. (LEXX)
Lexaria Bioscience Corp. (LEXX) reported revenue of US$0.71M and net income of -US$11.90M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-08-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.71M | US$0.70M | -US$11.88M | -US$11.90M | — |
| 2024 | US$0.46M | US$0.46M | -US$5.75M | -US$5.80M | — |
| 2023 | US$0.23M | US$0.19M | -US$6.53M | -US$6.66M | — |
| 2022 | US$0.26M | US$0.18M | -US$6.62M | -US$7.27M | — |
| 2021 | US$0.72M | US$0.55M | -US$5.69M | -US$4.03M | — |
Quarterly results
Data as of 2026-05-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-05-31 | US$0.00M | -US$1.99M | — |
| 2026-02-28 | US$0.02M | -US$1.45M | — |
| 2025-11-30 | US$0.00M | -US$1.60M | — |
| 2025-08-31 | US$0.17M | -US$2.70M | — |
| 2025-05-31 | US$0.17M | -US$3.79M | — |
| 2025-02-28 | US$0.17M | -US$2.71M | — |
| 2024-11-30 | US$0.18M | -US$2.70M | — |
| 2024-08-31 | US$0.08M | -US$2.18M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.